Jardiance sparked controversy with their commercial starring Deanna Colón that originally aired in April 2023. The ad ...

In 2025, health means staying alive from the inside. Taking advantage of the bedeviled blessing of insurance, scheduling ...

Eli Lilly and Company LLY reported first-quarter 2025 adjusted earnings per share (“EPS”) of $3.34, which missed the Zacks ...

Boehringer Ingelheim and Eli Lilly's SGLT2 inhibitor Jardiance has become the first drug in the class to be approved in the EU for all adults with symptomatic chronic heart failure (CHF), giving ...

The EMPACT-MI trial found that giving Boehringer Ingelheim and Eli Lilly’s SGLT2 drug Jardiance (empagliflozin) within 14 days of an acute myocardial infarction (AMI) reduced the risk of a ...

Jardiance is a medication doctors prescribe to treat heart failure and type 2 diabetes. Most Medicare Part D prescription drug plans include coverage for Jardiance. Part C plans with drug coverage ...

JARDIANCE is not recommended in patients with type 1 diabetes mellitus. It may increase their risk of diabetic ketoacidosis. JARDIANCE is not recommended for use to improve glycemic control in ...

Eli Lilly and Company (NYSE: LLY) today announced its financial results for the first-quarter of 2025. "Lilly had a solid ...

Revenues in the quarter also benefited from a one-time payment of $370 million from partner Boehringer Ingelheim due to an amendment in their collaboration for Jardiance. Mounjaro recorded sales ...